SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-19-006402
Filing Date
2019-04-15
Accepted
2019-04-15 16:46:40
Documents
6
Period of Report
2019-05-16
Effectiveness Date
2019-04-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0419_endralife.htm DEF 14A 642227
2 GRAPHIC endralife_logo.jpg GRAPHIC 115211
3 GRAPHIC sign001.jpg GRAPHIC 17903
4 GRAPHIC endralife_logo1.jpg GRAPHIC 115234
5 GRAPHIC sign002.jpg GRAPHIC 13609
6 GRAPHIC proxy_1.jpg GRAPHIC 712041
  Complete submission text file 0001213900-19-006402.txt   1960010
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37969 | Film No.: 19749052
SIC: 3845 Electromedical & Electrotherapeutic Apparatus